Day Case Laparoscopic Sacrocolpopexy, a New Management

Pelvic Organ Prolapse Clinical Trial

Official title: Day-case Laparoscopic Sacrocolpopexy, a Compelling Option in Selected Patients

Status Completed

Clinical Trial Summary

Facing the stakes of hospital beds, this study assessed day case variant technic of laparoscopic sacrocolpopexy with or without robotic assistant.

Clinical Trial Description

Pelvic organ prolapse (POP) is an increasingly common functional disorder which affects approximately 40% of female population. Of these 12% are symptomatic and suffer of physical and emotional distress. 11% will undergo a surgical procedure. Since its introduction by Lane in 1982, Sacrocolpopexy (SCP) became the surgical "gold standard" for correcting vaginal vault .

With minimal invasive approach, SCP had an mean hospitalization time of 3 to 7 days .

With rising health care cost and its inherent economic burden, safe and viable options to reduce cost must be sought.

Day case surgery has developed rapidly in the USA since the 1970s, and has spread to Europe, especially in Great Britain. But the High Authority of Health in France found a delay in its development.

In view of the evolution of surgical and anesthetic techniques, and the low complication rate of SCP, it seemed natural to imagine that this intervention could be done in an ambulatory setting. ;

Related Conditions & MeSH terms

• Pelvic Organ Prolapse
• Prolapse

• NCT number: NCT03607344
• Study type: Observational
• Source: Centre Hospitalier Universitaire de Nice
• Status: Completed
• Start date: January 1, 2016
• Completion date: June 30, 2018